Estimates Revisions BioNTech SE BOERSE MUENCHEN
Stocks
22UA
US09075V1026
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.15 EUR | -1.41% |
|
-4.81% | -1.41% |
| 10/07 | Polish air traffic control faces funding freeze over COVID vaccine ruling | RE |
| 09/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Consensus BioNTech SE
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
